NGL Fine-Chem announces Q2 FY26 unaudited results, auditor gives clean review

Results View source PDF Explain this filing

NGLFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹1445.00

prior close

₹1464.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-0.9% vs market

Pharmaceuticals peers, median of 157sector-0.0%-1.0% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-1.4

15m

-1.5

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0-0.1-0.9-0.0-1.0

Next day

-3.6-0.2-3.4-0.4-3.2

-7.4+0.4-7.8-0.3-7.1

-2.9-0.4-2.5-1.0-1.9

-5.9-0.6-5.3-1.3-4.6

-4.2-0.9-3.3-1.5-2.6

-8.6-3.0-5.6-3.2-5.4

15d

-10.7-3.9-6.9-3.4-7.3

-8.3-4.8-3.5-4.0-4.3

+0.4-7.8+8.1-6.9+7.2

+59.2-7.2+66.4-8.8+67.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NGL Fine-Chem board on November 12, 2025 approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. Statutory auditor Manek and Associates issued an unqualified limited review report. Consolidated results include subsidiary Macrotech Polychem Private Limited. Specific financial numbers are not included in the filing text.

Likely market impact

Routine quarterly results filing with clean auditor review, no red flags flagged. Neutral for shareholders pending actual numbers.